Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: kathleen who wrote (360)	7/15/1998 4:00:00 PM
From: Harry D. Kramer	Read Replies (1) \| Respond to of 586

An interesting point that you bring up, but I have to disagree with your conclusion. Yes, they have sold around 100,000 shares of Alfacell in the last two months, but they still own approximately 1.4 million shares of this company. That results in a loss of $2.5 million just for today (if the two Aries Funds held on to their shares as of today). BTW, the 2-year trading range is $8.13 - $2.25, currently the stock trades at $0.75. I think it is fair to say that ACEL is another black hole for Paramount. I really start to become skeptical about our fellow shareholder.